FARALLON CAPITAL MANAGEMENT LLC
Top Portfolio Positions
160 positions ·
$14,973,084,132 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
13,604,796 | $1,323,066,411 | 8.84% | |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
4,218,394 | $878,564,918 | 5.87% | |
| MSFT |
Microsoft Corp
Technology
|
2,344,779 | $867,966,842 | 5.80% | |
| AON |
Aon plc
Financial Services
|
2,512,638 | $811,029,293 | 5.42% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
9,365,463 | $695,479,282 | 4.64% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
6,348,906 | $669,174,692 | 4.47% | |
| NTRA |
Natera, Inc.
Healthcare
|
3,207,366 | $641,441,126 | 4.28% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
13,111,010 | $562,331,218 | 3.76% | |
| AVGO |
Broadcom Inc.
Technology
|
1,779,500 | $550,773,045 | 3.68% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
1,821,706 | $492,935,426 | 3.29% |
Portfolio Trend
25 quarters · across all stocks
Holdings in BBIO
Shares Held
Position Value (USD)
8 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $695,479,282 | 9,365,463 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $688,292,434 | 8,998,463 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $425,492,480 | 8,192,000 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $341,122,000 | 7,900,000 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $198,120,670 | 5,731,000 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $115,110,800 | 4,195,000 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $44,478,620 | 1,747,000 | Shares | Other | 2024-11-14 | |
| 2023-12-31 | $242,220 | 6,000 | Shares | Other | 2024-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||